Stocksigma LogoStocksigma Logo

Essix Biosciences Acquires 70 Lakh Warrants in Ind-Swift Laboratories via Preferential Issue

Essix Biosciences Limited, part of the promoter group of Ind-Swift Laboratories Limited, acquired 70,00,000 fully convertible warrants on a preferential

Essix Biosciences Acquires 70 Lakh Warrants in Ind-Swift Laboratories via Preferential Issue

Ind-Swift Laboratories Ltd 路 Acquisition/ Disposal of Shares 路 22 Sept 2026, 4:43 pm

Essix Biosciences Acquires 70 Lakh Warrants in Ind-Swift Laboratories via Preferential Issue Essix Biosciences Limited, part of the promoter group of Ind-Swift Laboratories Limited, acquired 70,00,000 fully convertible warrants on a preferential basis for cash on 17th Sep'26. The warrants represent 7.45% of the target company's total diluted share capital. Following this acquisition, the aggregate promoter and PACs holding stands at 42.93% of post-issue share capital (3,73,34,278 equity shares) and will increase to 47.18% on a fully diluted basis (4,43,34,278 shares/warrants) upon complete conversion, expanding the total diluted voting capital to 9,39,61,558 equity shares.

Original exchange filing (PDF)

More announcements from Ind-Swift Laboratories Ltd

All Ind-Swift Laboratories Ltd announcements